Concepedia

Christine Haller

CH

29

Publications

2.6K

Citations

22

H-Index

1970

Active since

Affiliations

University of California, San Francisco(Current)

San Francisco General Hospital

Amgen (United States)

Ultragenyx Pharmaceutical (United States)

BioMarin (United States)

Christine Haller is an author at University of California, San Francisco specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1970–2019

29

Publications

29

Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids

Christine Haller, N BENOWITZ · New England Journal of Medicine · 2000 · 960 citations · Full text

Dosing Algorithm for Warfarin Using <i>CYP2C9</i> and <i>VKORC1</i> Genotyping From a Multi-Ethnic Population: Comparison with Other Equations

Alan H.B. Wu, Ping Wang, Andrew Smith et al. · Pharmacogenomics · 2008 · 153 citations

Hemodynamic effects of ephedra-free weight-loss supplements in humans

Christine Haller, Neal L. Benowitz, Peyton Jacob · The American Journal of Medicine · 2005 · 137 citations

, , +8

Prevalence of Smoking Assessed Biochemically in an Urban Public Hospital: A Rationale for Routine Cotinine Screening

N BENOWITZ, Kathleen Schultz, Christine Haller et al. · American Journal of Epidemiology · 2009 · 119 citations · Full text

, , +20

Pharmacology of ephedra alkaloids and caffeine after single‐dose dietary supplement use

Christine Haller, Peyton Jacob, Neal L. Benowitz · Clinical Pharmacology & Therapeutics · 2002 · 118 citations

Rows per page

1–5 of 29